Skip to content
Screener

Free cash flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.09B-13.2%
Pfizer logo
PfizerPFE
$2.18B+23.0%
Merck & Co. logo
Merck & Co.MRK
$4.48B+77.0%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$32.44M+1.5%
Nuvation Bio logo
Nuvation BioNUVB
-$43.22M+10.6%

Other financials

Income statement

See full
Revenue-
Operating income-$14.1M-146%
Net income-$14.2M-151%
EPS (diluted)-$0.58-93.3%

Balance sheet

See full
Cash & equivalents$2.0M+1,478%
Total debt$648.2K+63.9%
Total equity-$18.5M-56.8%
Total assets$5.2M+75.1%

Cash flow

See full
Operating cash flow-$4.8M+10.3%
CapEx$125.0K

Valuation

See full
Market cap$86.13M-57.9%
Enterprise value$84.8M-58.6%
P/S1,435.7×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%

Returns & leverage

See full
Return on equity311.1%
Debt / equity-0×
Current ratio0.2×+0.1×

Where this comes from

Calculated from Neonc Technologies Holdings’s reported figures.

The source filing: Neonc Technologies Holdings’s 10-K, filed March 31, 2026. Open the filing →

Filed
Mar 31, 2026, 6:05 AM EDT
Fiscal year
FY2025
Accession
0001829126-26-002860

FAQ

What is Neonc Technologies Holdings's free cash flow?
Neonc Technologies Holdings (NTHI) reported free cash flow of -$5.22M in Q4 2025.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Neonc Technologies Holdings's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude